Team

Founded by a Stanford M.D./Ph.D., and a Harvard Business School/UW Madison Engineer who came together through a shared vision of improving patient outcomes with innovative and early, non-invasive detection of bio markers for cancer and neurological diseases. 

Our Vision 
To create and support broad market solutions for early cancer detection to save millions of lives

Diagnose Early Approach

approach.png


 
 
Diagnose_Early_logo.png
  1. Identify breath bio markers for the detection of diseases such as cancer and neurological conditions

  2. Save millions of lives by using breath based diagnostics combined with other bio markers to diagnose early

  3. Commercialize an inexpensive, non-invasive, annual health screen

Global Causes of Cancer:

90-95% environment and lifestyle driven. Environmental causes of cancer include smoking, diet, obesity, infections, radiation, stress, lack of exercise, toxins and pollution.

90-95% environment and lifestyle driven. Environmental causes of cancer include smoking, diet, obesity, infections, radiation, stress, lack of exercise, toxins and pollution.

5-15% genetically driven. Fewer cell mutations are required for certain cancers to develop in patients that inherit a predisposition for the disease.

5-15% genetically driven. Fewer cell mutations are required for certain cancers to develop in patients that inherit a predisposition for the disease.


  • 18.1 million new cancer cases each year

  • 9.5 million deaths each year

  • Over 1.7 million new US cases of cancer diagnosed annually in the United States over 600,000 die from the disease (2018 estimate)

  • Annual direct cost of cancer care is approximately $150Bn in the US alone and is much higher elsewhere in the world

  • Indirect costs due to loss of work are also over $100Bn

  • Number of cases and cost will increase due to aging population

  • Diagnose Early utilizes central labs to perform analysis

  • Point of care solutions do not allow comprehensive analysis of highly complex bio samples, such as breath

  • Diagnose Early uses proprietary technology to collect and analyze samples in our central lab located in Northern California

Team

Diagnose Early came together through a shared vision of improving patient outcomes
with innovative and early, non-invasive detection of bio markers for cancer and neurological diseases.

 

Dr. John Cunniff, M.D./Ph.D.
Founder & CEO
Bio

Mr. Chris Wheeler
Founder & Chairman
Bio

 

Dr. Karl-Magnus Larsson, Ph.D.
Chief Science Officer
Bio

Mr. Peter Holst
Chief Technology Officer
Bio


Dr. Boris Fain, Ph.D.
Founder & Analytics Advisor
Bio

Dr. Christopher Lock, M.D./Ph.D.
Advisor & MS Clinical Lead at Stanford
Bio

Diagnose Early is also a proud member of Stanford

 
 

Diagnose Early is headquartered in Silicon Valley, birthplace of the world's most successful tech and biotech companies.

39655 Eureka Drive
Newark, CA 94560
(415) 595-4911
chriswheeler@diagnoseearly.com